-
Product Insights
NewB And T Lymphocyte Attenuator – Drugs In Development, 2024
The B And T Lymphocyte Attenuator pipeline drugs market research report outlays comprehensive information on the B And T Lymphocyte Attenuator targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Oncology, and Dermatology which include indications of Graft Versus Host Disease (GVHD), Autoimmune Disorders, Solid Tumor, Renal Cell Carcinoma, and Atopic Dermatitis (Atopic Eczema). It also reviews...
-
Product Insights
NewT Cell Immunoreceptor With Ig And ITIM Domains – Drugs In Development, 2024
The T Cell Immunoreceptor With Ig And ITIM Domains pipeline drugs market research report outlays comprehensive information on the T Cell Immunoreceptor With Ig And ITIM Domains targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Undisclosed which include indications of Solid Tumor, Non-Small Cell Lung Cancer, and Unspecified. It also reviews key players involved in...
-
Product Insights
NewInducible T Cell Costimulator – Drugs In Development, 2024
The Inducible T Cell Costimulator pipeline drugs market research report outlays comprehensive information on the Inducible T Cell Costimulator targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Metabolic Disorders, and Ophthalmology which include indications of Non-Small Cell Lung Cancer, Head And Neck Squamous Cell Carcinoma (HNSC), Systemic Lupus Erythematosus, Type 1 Diabetes (Juvenile Diabetes), and...
-
Product Insights
NewVoltage Dependent T Type Calcium Channel Subunit Alpha 1I – Drugs In Development, 2024
The Voltage Dependent T Type Calcium Channel Subunit Alpha 1I pipeline drugs market research report outlays comprehensive information on the Voltage Dependent T Type Calcium Channel Subunit Alpha 1I targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, and Dermatology which include indications of Alzheimer's Disease, Neuropathic Pain (Neuralgia), and Pruritus. It also reviews key...
-
Product Insights
NewT Lymphocyte Activation Antigen CD86 – Drugs In Development, 2024
The T Lymphocyte Activation Antigen CD86 pipeline drugs market research report outlays comprehensive information on the T Lymphocyte Activation Antigen CD86 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Infectious Disease, Oncology, and Central Nervous System which include indications of Rheumatoid Arthritis, Graft Versus Host Disease (GVHD), Infectious Disease, Coronavirus Disease 2019 (COVID-19), Oncology, Melanoma, Alzheimer's...
-
Product Insights
NewT Cell Surface Glycoprotein CD4 – Drugs In Development, 2024
The T Cell Surface Glycoprotein CD4 pipeline drugs market research report outlays comprehensive information on the T Cell Surface Glycoprotein CD4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Immunology, Respiratory, and Central Nervous System which include indications of Human Immunodeficiency Virus (HIV) Infections (AIDS), Graft Versus Host Disease (GVHD), Immunology, Asthma, and Chronic Inflammatory...
-
Product Insights
NewV Type Immunoglobulin Domain Containing Suppressor of T Cell Activation – Drugs In Development, 2024
The V Type Immunoglobulin Domain Containing Suppressor of T Cell Activation pipeline drugs market research report outlays comprehensive information on the V Type Immunoglobulin Domain Containing Suppressor of T Cell Activation targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, and Central Nervous System which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Psoriasis, Autoimmune...
-
Product Insights
NewCytotoxic T Lymphocyte Protein 4 – Drugs In Development, 2024
The Cytotoxic T Lymphocyte Protein 4 pipeline drugs market research report outlays comprehensive information on the Cytotoxic T Lymphocyte Protein 4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Infectious Disease, and Genetic Disorders which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Rheumatoid Arthritis, Graft Versus Host Disease (GVHD), Epstein–Barr Virus (HHV-4) Infections,...
-
Product Insights
NewT Cell Surface Glycoprotein CD3 Epsilon Chain – Drugs In Development, 2024
The T Cell Surface Glycoprotein CD3 Epsilon Chain pipeline drugs market research report outlays comprehensive information on the T Cell Surface Glycoprotein CD3 Epsilon Chain targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Metabolic Disorders, and Central Nervous System which include indications of Follicular Lymphoma, Marginal Zone B-cell Lymphoma, Psoriasis, Rheumatoid Arthritis, Type 1 Diabetes...
-
Product Insights
NewT Lymphocyte Activation Antigen CD80 – Drugs In Development, 2024
The T Lymphocyte Activation Antigen CD80 pipeline drugs market research report outlays comprehensive information on the T Lymphocyte Activation Antigen CD80 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Metabolic Disorders, and Central Nervous System which include indications of Solid Tumor, Gastric Cancer, Rheumatoid Arthritis, Graft Versus Host Disease (GVHD), Type 1 Diabetes (Juvenile Diabetes),...